Newsletter of COMPAMED | View in browser | Deutsch | Print
Image: Header picture of COMPAMED Newsletter

Point-of-Care diagnostics for multiple diseases

Dear Sir or Madam,

By now, we are all experts in performing a Corona rapid test. But what if you could test for multiple diseases at once with just one rapid test? A team coordinated by Fraunhofer IZM is currently working on a project that could revolutionize point-of-care diagnostics. Find out exactly how it works and how advanced the project is in our interview.

Enjoy reading!

Anne Hofmann
Editorial team


Interview: PoC diagnostics
Newsletter Service
Newsletter Archive
RSS Service
Image: Banner with the text: COMPAMED Magazine - 365 days a year; Copyright: Messe Düsseldorf

Bone formation comes down to the nanowire

Laboratory Medicine & Hygiene

A nanotechnology platform developed by KAUST scientists could lead to new treatments for degenerative bone diseases.
read more
To top

Point-of-Care diagnostics for multiple diseases

COMPAMED talks about ...

Image: several sealed rapid antigen tests; Copyright: twenty20photo
The Fraunhofer IZM is coordinating the PoC-BoSens project, which comprises a transnational team from various specialist fields that developed a biosensor prototype that can reliably quantify the biomarkers for several infectious diseases in less than 15 minutes.
Read more in the interview!
Point-of-Care diagnostics for multiple diseases
All interviews at
To top

A major step forward for organ biofabrication


Bioengineers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed the first biohybrid model of human ventricles with helically aligned beating cardiac cells, and have shown that muscle alignment does, in fact, dramatically increases how much blood the ventricle can pump with each contraction.
read more
To top

Dissolving implantable device relieves pain without drugs


A Northwestern University-led team of researchers has developed a small, soft, flexible implant that relieves pain on demand and without the use of drugs. The first-of-its-kind device could provide a much-needed alternative to opioids and other highly addictive medications.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to

To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Bernhard J. Stempfle, Erhard Wienkamp

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.